StockMarketWire.com - Biopharmaceutical company PureTech Health said it was "exploring the potential" for a listing on the Nasdaq stock exchange in the United States.

The US listing would be expected to include an issue of new ordinary shares underlying the the American Depository Shares that represented ordinary company shares.

However, it said the terms of any US listing had not yet been determined and there could be no assurance as to the timing or completion of any such listing.

The firm said it intended for the potential US listing to be in addition to its premium listing on the Official List of the UK Financial Conduct Authority and trading on the main market of the London Stock Exchange.

A further announcement would be made "if and when appropriate".


At 8:05am: [LON:PRTC] PureTech Health Plc share price was -1.5p at 230.5p



Story provided by StockMarketWire.com